These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 10955455
1. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A. Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455 [Abstract] [Full Text] [Related]
2. Cyclin D1 protein expression in human thyroid gland and thyroid cancer. Temmim L, Ebraheem AK, Baker H, Sinowatz F. Anat Histol Embryol; 2006 Apr; 35(2):125-9. PubMed ID: 16542178 [Abstract] [Full Text] [Related]
3. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O. Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501 [Abstract] [Full Text] [Related]
4. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors. Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Satacińska-Los E, Kulig A, Włoch J. Pol J Pathol; 2005 Aug; 56(1):27-35. PubMed ID: 15921011 [Abstract] [Full Text] [Related]
5. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma. Lee SH, Lee JK, Jin SM, Lee KC, Sohn JH, Chae SW, Kim DH. Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376 [Abstract] [Full Text] [Related]
6. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV. Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687 [Abstract] [Full Text] [Related]
7. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions. Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK. J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874 [Abstract] [Full Text] [Related]
8. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. Wang S, Wuu J, Savas L, Patwardhan N, Khan A. Hum Pathol; 1998 Nov; 29(11):1304-9. PubMed ID: 9824112 [Abstract] [Full Text] [Related]
9. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions. Brzeziańska E, Cyniak-Magierska A, Sporny S, Pastuszak-Lewandoska D, Lewiński A. Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985 [Abstract] [Full Text] [Related]
10. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJ, Wiseman SM. Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495 [Abstract] [Full Text] [Related]
11. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, Napolitano M, Tavernise B, Fusco A, Viglietto G. Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252 [Abstract] [Full Text] [Related]
13. Expression of S100A2 and S100A6 in thyroid carcinomas. Ito Y, Yoshida H, Tomoda C, Uruno T, Miya A, Kobayashi K, Matsuzuka F, Kakudo K, Kuma K, Miyauchi A. Histopathology; 2005 May; 46(5):569-75. PubMed ID: 15842639 [Abstract] [Full Text] [Related]
14. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ. J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413 [Abstract] [Full Text] [Related]
15. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression. Lantsov D, Meirmanov S, Nakashima M, Kondo H, Saenko V, Naruke Y, Namba H, Ito M, Abrosimov A, Lushnikov E, Sekine I, Yamashita Sh. Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225 [Abstract] [Full Text] [Related]
16. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma. Erickson LA, Yousef OM, Jin L, Lohse CM, Pankratz VS, Lloyd RV. Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042 [Abstract] [Full Text] [Related]
17. The expression and role of serum response factor in papillary carcinoma of the thyroid. Kim HJ, Kim KR, Park HS, Jang KY, Chung MJ, Shong M, Moon WS. Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551 [Abstract] [Full Text] [Related]
18. [Poorly differentiated carcinoma of the thyroid--immunohistochemical evaluation of p53 and p27 protein expression]. Wierzchowski W, Szybiński P, Nowak W, Nowak K, Szybiński Z, Buziak-Bereza M, Stachura J. Wiad Lek; 2001 Jul; 54 Suppl 1():79-87. PubMed ID: 12182066 [Abstract] [Full Text] [Related]
19. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study. Lin BT, Brynes RK, Gelb AB, McCourty A, Amin MB, Medeiros LJ. Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205 [Abstract] [Full Text] [Related]
20. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid. Ito Y, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A. Anticancer Res; 2003 Nov; 23(5A):3819-24. PubMed ID: 14666683 [Abstract] [Full Text] [Related] Page: [Next] [New Search]